查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439934

全球電泳市場：洞察、競爭格局、市場預測：2030 年

Electrophoresis - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2024年至2030年的預測期內，全球電泳市場規模預計將以5.83%的複合年增長率擴大。 電泳市場受肺癌、結腸癌、類風濕性關節炎、多發性骨髓瘤、慢性淋巴細胞白血病、囊性纖維化、亨廷頓病、ALPHA地中海貧血等癌症、傳染病和遺傳性疾病的流行推動，市場成長顯著由於增加 由於電泳用於檢測上述疾病，預計這些疾病盛行率的上升將在未來幾年增加對電泳的需求。 此外，研發活動的產學合作不斷增多，毛細管電泳與新一代定序和質譜技術在各種慢性疾病診斷中的應用不斷增加，設備、試劑和設備的監管機構也越來越多。由於市場主要進入者的批准活動不斷增加，預計在2024 年至2030 年的預測期內，該軟體將以顯著的複合年增長率增長。

推動電泳市場的關鍵因素之一是全球各種癌症、傳染病和遺傳疾病的負擔日益增加。

根據世界衛生組織 (WHO) 2022 年的數據，癌症是全球頭號死因，2020 年約有 1000 萬人因癌症死亡。 2020年，全球新增乳癌病例226萬例。 221萬人罹患肺癌，193萬人罹患大腸癌，141萬人罹患攝護腺癌，120萬人罹患皮膚癌，109萬人罹患胃癌。

此外，根據聯合國愛滋病規劃署的最新數據，2020年全球有近3,770萬人感染愛滋病毒，2020年新增愛滋病毒感染者150萬人。

隨著癌症和傳染病在世界各地的盛行率不斷增加，由於電泳設備用於診斷上述疾病，因此對電泳的需求預計會增加。

本報告考察了全球電泳市場，並提供了市場概述，包括按類型、產品、應用、最終用戶、地區以及參與市場的公司概況劃分的趨勢。

目錄

第1章電泳市場報告簡介

第2章電泳市場摘要

第3章監理分析

第4章電泳市場主要因素分析

  • 推動電泳市場的因素
  • 電泳市場的抑制因素與挑戰
  • 電泳市場機會

第5章電泳市場的波特五力分析

第6章COVID-19對電泳市場的影響分析

第7章電泳市場概況

  • 依類型
  • 按產品
  • 依用途
  • 按最終用戶
  • 按地區

第8章電泳市場公司及產品概況

  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Agilent Technologies
  • Danaher.
  • Merck KGaA
  • PerkinElmer Inc.
  • Hoefer Inc.
  • QIAGEN
  • Lonza Group Ltd.
  • Shimadzu Corporation.
  • Harvard Bioscience
  • CBS Scientific.
  • Lumex Instruments
  • Cleaver Scientific
  • Sebia
  • Synoptics Ltd
  • ACTGene Inc.
  • Analytik Jena GmbH
  • Cytiva

第9章KOL瀏覽量

第 10 章專案方法

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

Product Code: DIMDCL0615

Electrophoresis Market By Type (DNA Electrophoresis, RNA Electrophoresis, And Protein Electrophoresis), By Product (Gel Electrophoresis, Capillary Electrophoresis, Reagents & Consumables, And Others), By Application (Diagnosis, Research & Development, Quality Control & Process Validation, And Others), By End-User (Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Hospitals & Diagnostic Laboratories, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of various cancer, infectious, and genetic disorder and surging number of industry-academia research collaboration for research & developmental activities

The global electrophoresis market is estimated to grow at a CAGR of 5.83% during the forecast period from 2024 to 2030. The electrophoresis market is observing substantial market growth due to the growing prevalence of cancers, infectious, and genetic diseases such as lung cancer, colon cancer, rheumatoid arthritis, multiple myeloma, chronic lymphocytic leukemia, cystic fibrosis, Huntington's disease, alpha thalassemia, and others. Electrophoresis is used for the detection of the aforementioned diseases, therefore the increasing prevalence of these diseases will increase the demand for electrophoresis in the upcoming years. Furthermore, the surging number of industry-academia research collaborations for R&D activities, the increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis of various chronic diseases, the increasing approval activities by regulatory authorities for devices, reagents, and software, and the presence of key players in the market will create a requisite for electrophoresis in the market. Therefore, the electrophoresis market is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Electrophoresis Market Dynamics:

One of the key aspects for driving the electrophoresis market is the rising burden of various cancers, infectious, and genetic diseases across the globe.

According to the World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 were 2.26 million cases, across the globe. The same source stated that lung cancer accounted for 2.21 million new cases, colon and rectum cancer for 1.93 million new cases, prostate cancer with 1.41 million new cases, skin cancer accounted for 1.20 million new cases, and stomach cancer was 1.09 million, 2020, globally.

Additionally, according to the latest data provided by UNAIDS, nearly 37.7 million people globally were living with HIV in 2020, and 1.5 million people became newly infected with HIV in 2020.

Thus, the increasing prevalence of cancer and infectious ailments across the globe will increase the demand for electrophoresis as these devices are used for the diagnosis of the afore-said diseases.

Additionally, the increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for the diagnosis of various chronic diseases and research & developmental activities will lead to an increased demand for electrophoresis. High-throughput proteomics technologies combined with advanced bioinformatics are extensively used to identify molecular signatures of diseases based on protein pathways and signaling cascades. Mass spectrometry plays a vital role in proteomics and has become an indispensable tool in molecular and cellular biology.

Furthermore, surging product approvals across the globe will in turn increase the demand for electrophoresis during the forecast period. For instance, in May 2019, the US FDA issued clearance for HYDRASYS 2, which is developed by Sebia, Inc., which is a leading provider of clinical protein electrophoresis equipment and reagents used for various disease screening and monitoring. HYDRASYS 2 is an all-in-one gel electrophoresis system with perforce staining, scanning, and migration.

Therefore, the factors stated above collectively will drive the overall Electrophoresis market throughout the forecast period from 2024-2030.

However, the time-consuming process, the presence of alternative techniques, and others may halt the market growth of electrophoresis.

The electrophoresis market was positively impacted during the period of COVID- 19 pandemic. During the initial stage of the pandemic, the sale of electrophoresis suffered collapse owing to the imposition of strict lockdown rules, disruption in manufacturing, and supply. However, the electrophoresis technique was used in the development of the Covid-19 vaccine. For instance, in July 2022, Elsan conducted a clinical trial to assess serum inflammation profiles by protein electrophoresis, a type of electrophoresis technique on patients hospitalized for infection due to the SARS-CoV-2 virus. On the other hand, gel electrophoresis, a type of electrophoresis was even used for the detection of the Covid-19 virus. Thus, as the number of cases of covid-19 increases, the demand for electrophoresis rises drastically. Likewise, the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and with the increasing demand of electrophoresis for detection and research purposes, the demand for electrophoresis increases and is anticipated to do the same during the forecast period from 2022 - 2028.

Electrophoresis Market Segment Analysis:

Electrophoresis Market by Type (DNA Electrophoresis, RNA Electrophoresis, and Protein Electrophoresis), Product (Gel Electrophoresis, Capillary Electrophoresis, Reagents & Consumables, and Others), Application (Diagnosis, Research & Development, Quality Control & Process Validation, and Others), End-User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the electrophoresis market, the gel electrophoresis segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the low operating and instrument costs, rising applications in the pharmaceutical and biotechnology industries, and the increasing burden of infectious diseases, cancer, and genetic disorders.

Also, the expanding launches and strategic investments, and other activities by the key players related to the segment will support driving its market during the forecast period.

The gel electrophoresis technique is used to identify many proteins that are significant for improved characterization of tumor progression and molecular specificity of both lung cancer subtypes. As a result of gel electrophoresis, it is possible to distinguish proteins from tumor cells, which aids in tumor diagnosis and may contribute to the segment's growth.

Further, various strategic steps taken by the key players in the market will help in increasing the demand for gel electrophoresis. For instance, in September 2020, miniPCR bio launched GELATO, a gel electrophoresis system with an integrated blue light with transillumination technology, allowing simultaneous nucleic acid separation.

Therefore, owing to the above-mentioned factors, the demand for gel electrophoresis upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global electrophoresis market during the forecast period.

North America is expected to dominate the overall Electrophoresis Market:

Among all the regions, North America is expected to dominate the global electrophoresis in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing demand for electrophoresis in the region owing to the increasing number of genomic research projects, the growing prevalence of chronic diseases; collaborations between industry and academia, surging product approvals and launches, and others are among the key factors that contribute to the growth of the electrophoresis market in North America during the forecast period from 2022 - 2028.

For instance, according to GLOBOCAN 2022, the total number of new cancer cases was 2,281,658 in the United States, in 2020. The rising cases of cancers will increase the demand for electrophoresis as these devices are used for the detection of tumors in a sample.

Further, the pharmaceutical and biopharmaceutical industries in the region are increasing R&D investment. For instance, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry in the United States is one of the top world leaders in new drug development. In 2020, the entire biopharmaceutical and pharmaceutical industry invested an estimated USD 91.1 billion in research and development (R&D), up from approximately USD 83 billion in 2019. It is expected that research and development activity will increase in the same manner during the forecast period, ultimately increasing the demand for electrophoresis reagents and devices, thereby surging overall market growth of electrophoresis.

Moreover, the market players are continuously concentrating on the development of advanced electrophoresis devices and reagents, and this is likely to drive the market in the region. For instance, in September 2022, a novel capillary electrophoresis system, BioPhase8800, was introduced by Sciex Company for biological characterization during biopharmaceutical therapy. The new device analyzes eight samples simultaneously and is a multi-capillary system for capillary electrophoresis sodium dodecyl sulfate (CE-SDS).

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the electrophoresis market.

Electrophoresis Market Key Players:

Some of the key market players operating in the electrophoresis market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Agilent Technologies, Danaher., Merck KGaA, PerkinElmer Inc., Hoefer Inc., QIAGEN, Lonza Group Ltd., Shimadzu Corporation., Harvard Bioscience, CBS Scientific., Lumex Instruments, Cleaver Scientific, Sebia, Synoptics Ltd, ACTGene Inc., Analytik Jena GmbH, Cytiva, and others.

Recent Developmental Activities in the Electrophoresis Market:

In September 2022, miniPCR bio, a developer of scientific equipment for researchers, unveiled the BanditTM STEM Electrophoresis Kit, an educational electrophoresis device. Bandit is a low-cost STEM activity kit that allows kids to build and operate a functioning gel electrophoresis device.

In August 2022, Amerigo Scientific, a distributor focused on supplying products and services to the biomedical and life science communities, announced the release of their new CALX8 Reagent for life science laboratory scientists. This reagent is extensively used in molecular biology research, such as cell lysis, protein purification, electrophoresis, and immunoassays.

In September 2020, Hitachi High-Tech Corporation, based in Japan, launched a Hitachi DS3000 compact capillary electrophoresis (CE) sequencer in collaboration with Promega Corporation, based in the United States. The Hitachi DS3000 is an easy-to-use, portable CE sequencer that can be used for verifying significant amounts of gene-sequence data that have been analyzed by next-generation sequencers and carrying out fragment analysis used in human identification.

Key Takeaways from the Electrophoresis Market Report Study

  • Market size analysis for current electrophoresis market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the electrophoresis market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global electrophoresis market.
  • Various opportunities available for the other competitor in the electrophoresis market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current electrophoresis market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for electrophoresis market growth in the coming future?

Target Audience who can be benefited from this Electrophoresis Market Report Study

  • Electrophoresis providers
  • Research organizations and consulting companies
  • Electrophoresis-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in electrophoresis
  • Various end users who want to know more about the electrophoresis market and the latest developments in the electrophoresis market.

Frequently Asked Questions for the Electrophoresis Market:

1. What is Electrophoresis?

Electrophoresis is a procedure to separate and/or purify the molecules like nucleic acids and proteins, under the influence of electricity. It is one of the most conventional techniques used in biotechnology, which separates the particles based on the charge and size they possess. This technology can be used for the diagnosis of various diseases, DNA sequencing, analysis of antibodies and steroids, and other medical research activities.

2. What is the global market for electrophoresis?

The global electrophoresis market is estimated to grow at a CAGR of 5.83% during the forecast period from 2024 to 2030.

3. What are the drivers for the global electrophoresis market?

The electrophoresis market is witnessing positive market growth owing to the factors such as growing incidence of cancer, infectious disease, and genetic disorder, surging number of industry-academia research collaborations for R&D, increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis, increasing approval activities by regulatory authorities for devices, reagent, and software, surging new devices launches, presence of key players in the market, and others will create an exigency for the electrophoresis market.

4. Who are the key players operating in the global electrophoresis market?

Some of the key market players operating in the electrophoresis market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Agilent Technologies, Danaher., Merck KGaA, PerkinElmer Inc., Hoefer Inc., QIAGEN, Lonza Group Ltd., Shimadzu Corporation., Harvard Bioscience, CBS Scientific., Lumex Instruments, Cleaver Scientific, Sebia, Synoptics Ltd, ACTGene Inc., Analytik Jena GmbH, Cytiva, and others.

5. Which region has the highest share of the electrophoresis market?

Among all the regions, North America is estimated to hold a significant revenue share in the global electrophoresis market. This can be ascribed to the increasing demand for electrophoresis among the patients in the region owing to the increasing prevalence of various cancers, infectious, and genetic disorders. Further, the rising burden of geriatric patients prone to chronic diseases, increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis, and the presence of key domicile players in the region are the reasons which act as a supportive factor for the North America Electrophoresis market growth.

Table of Contents

1.Electrophoresis Market Report Introduction

2. Electrophoresis Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

4. Electrophoresis Market Key Factors Analysis

  • 4.1. Electrophoresis Market Drivers
    • 4.1.1. Growing incidence of cancer, infectious disease, and genetic disorder
    • 4.1.2. The surging number of industry-academia research collaborations for R&D
    • 4.1.3. Increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis
    • 4.1.4. Increasing approval activities by regulatory authorities for devices, reagents, and software
  • 4.2. Electrophoresis Market Restraints and Challenges
    • 4.2.1. Time-consuming process
    • 4.2.2. Presence of alternative techniques
  • 4.3. Electrophoresis Market Opportunities
    • 4.3.1. Increasing funding for genomic, proteomic, and electrophoresis techniques in emerging countries
    • 4.3.2. The rise in the number of forensic, clinical, and research laboratories in developing countries

5. Electrophoresis Market Porter's Five Forces Analysis

  • 5.1 .Bargaining Power of Suppliers
  • 5.2 .Bargaining Power of Consumers
  • 5.3 .Threat of New Entrants
  • 5.4 .Threat of Substitutes
  • 5.5 .Competitive Rivalry

6. COVID-19 Impact Analysis on Electrophoresis Market

7. Electrophoresis Market Layout

  • 7.1. By Type
    • 7.1.1. DNA Electrophoresis
    • 7.1.2. RNA Electrophoresis
    • 7.1.3. Protein Electrophoresis
  • 7.2. By Product
    • 7.2.1. Gel Electrophoresis
    • 7.2.2. Capillary Electrophoresis
    • 7.2.3. Reagents & Consumables
    • 7.2.4. Others
  • 7.3. By Application
    • 7.3.1. Diagnosis
    • 7.3.2. Research & Development
    • 7.3.3. Quality control and Process Validation
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Academic and Research Institutions
    • 7.4.2. Pharmaceutical and Biotechnology Companies
    • 7.4.3. Hospitals & Diagnostic Laboratories
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Electrophoresis Market in USD million (2021-2030)
      • 7.5.1.2. Canada Electrophoresis Market in USD million (2021-2030)
      • 7.5.1.3. Mexico Electrophoresis Market in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Electrophoresis Market in USD million (2021-2030)
      • 7.5.2.2. Germany Electrophoresis Market in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Electrophoresis Market in USD million (2021-2030)
      • 7.5.2.4. Italy Electrophoresis Market in USD million (2021-2030)
      • 7.5.2.5. Spain Electrophoresis Market in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Electrophoresis Market in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Electrophoresis Market in USD million (2021-2030)
      • 7.5.3.2. Japan Electrophoresis Market in USD million (2021-2030)
      • 7.5.3.3. India Electrophoresis Market in USD million (2021-2030)
      • 7.5.3.4. Australia Electrophoresis Market in USD million (2021-2030)
      • 7.5.3.5. South Korea Electrophoresis Market in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia Pacific Electrophoresis Market in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Electrophoresis Market in USD million (2021-2030)
      • 7.5.4.2. Africa Electrophoresis Market in USD million (2021-2030)
      • 7.5.4.3. South America Electrophoresis Market in USD million (2021-2030)

8. Electrophoresis Market Company and Product Profiles

  • 8.1. Bio-Rad Laboratories, Inc
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Thermo Fisher Scientific, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. GE Healthcare
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Agilent Technologies
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Danaher.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Merck KGaA
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. PerkinElmer Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Hoefer Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. QIAGEN
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Lonza Group Ltd.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Shimadzu Corporation.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Harvard Bioscience
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. CBS Scientific.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Lumex Instruments
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Cleaver Scientific
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Sebia
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Synoptics Ltd
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. ACTGene Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Analytik Jena GmbH
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Cytiva
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Electrophoresis Market
  • Table 3: Electrophoresis Market Analysis in Global (2021-2030)
  • Table 4: Electrophoresis Market Analysis in Global by Type (2021-2030)
  • Table 5: Electrophoresis Market Analysis in Global by Product (2021-2030)
  • Table 6: Electrophoresis Market Analysis in Global by Application (2021-2030)
  • Table 7: Electrophoresis Market Analysis in Global by End-User (2021-2030)
  • Table 8: Electrophoresis Market Analysis in Global by Geography (2021-2030)
  • Table 9: Electrophoresis Market Analysis in North America (2021-2030)
  • Table 10: Electrophoresis Market Analysis in North America by Country (2021-2030)
  • Table 11: Electrophoresis Market Analysis in the US (2021-2030)
  • Table 12: Electrophoresis Market Analysis in Canada (2021-2030)
  • Table 13: Electrophoresis Market Analysis in Mexico (2021-2030)
  • Table 14: Electrophoresis Market Analysis in Europe (2021-2030)
  • Table 15: Electrophoresis Market Analysis in Europe by Country (2021-2030)
  • Table 16: Electrophoresis Market Analysis in France (2021-2030)
  • Table 17: Electrophoresis Market Analysis in Germany (2021-2030)
  • Table 18: Electrophoresis Market Analysis in the UK (2021-2030)
  • Table 19: Electrophoresis Market Analysis in Italy (2021-2030)
  • Table 20: Electrophoresis Market Analysis in Spain (2021-2030)
  • Table 21: Electrophoresis Market Analysis in the Rest of Europe (2021-2030)
  • Table 22: Electrophoresis Market Analysis in Asia-Pacific (2021-2030)
  • Table 23: Electrophoresis Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24: Electrophoresis Market Analysis in China (2021-2030)
  • Table 25: Electrophoresis Market Analysis in Japan (2021-2030)
  • Table 26: Electrophoresis Market Analysis in India (2021-2030)
  • Table 27: Electrophoresis Market Analysis in Australia (2021-2030)
  • Table 28: Electrophoresis Market Analysis in South Korea (2021-2030)
  • Table 29: Electrophoresis Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 30: Electrophoresis Market Analysis in the Rest of the World (2021-2030)
  • Table 31: Electrophoresis Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 32: Electrophoresis Market Analysis in the Middle East (2021-2030)
  • Table 33: Electrophoresis Market Analysis in Africa (2021-2030)
  • Table 34: Electrophoresis Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Electrophoresis Market
  • Figure 3: Electrophoresis Market Analysis in Global (2021-2030)
  • Figure 4: Electrophoresis Market Analysis in Global by Type (2021-2030)
  • Figure 5: Electrophoresis Market Analysis in Global by Product (2021-2030)
  • Figure 6: Electrophoresis Market Analysis in Global by Application (2021-2030)
  • Figure 7: Electrophoresis Market Analysis in Global by End-User (2021-2030)
  • Figure 8: Electrophoresis Market Analysis in Global by Geography (2021-2030)
  • Figure 9: Electrophoresis Market Analysis in North America (2021-2030)
  • Figure 10: Electrophoresis Market Analysis in North America by Country (2021-2030)
  • Figure 11: Electrophoresis Market Analysis in the US (2021-2030)
  • Figure 12: Electrophoresis Market Analysis in Canada (2021-2030)
  • Figure 13: Electrophoresis Market Analysis in Mexico (2021-2030)
  • Figure 14: Electrophoresis Market Analysis in Europe (2021-2030)
  • Figure 15: Electrophoresis Market Analysis in Europe by Country (2021-2030)
  • Figure 16: Electrophoresis Market Analysis in France (2021-2030)
  • Figure 17: Electrophoresis Market Analysis in Germany (2021-2030)
  • Figure 18: Electrophoresis Market Analysis in the UK (2021-2030)
  • Figure 19: Electrophoresis Market Analysis in Italy (2021-2030)
  • Figure 20: Electrophoresis Market Analysis in Spain (2021-2030)
  • Figure 21: Electrophoresis Market Analysis in the Rest of Europe (2021-2030)
  • Figure 22: Electrophoresis Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23: Electrophoresis Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24: Electrophoresis Market Analysis in China (2021-2030)
  • Figure 25: Electrophoresis Market Analysis in Japan (2021-2030)
  • Figure 26: Electrophoresis Market Analysis in India (2021-2030)
  • Figure 27: Electrophoresis Market Analysis in Australia (2021-2030)
  • Figure 28: Electrophoresis Market Analysis in South Korea (2021-2030)
  • Figure 29: Electrophoresis Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 20: Electrophoresis Market Analysis in the Rest of the World (2021-2030)
  • Figure 31: Electrophoresis Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 32: Electrophoresis Market Analysis in the Middle East (2021-2030)
  • Figure 33: Electrophoresis Market Analysis in Africa (2021-2030)
  • Figure 34: Electrophoresis Market Analysis in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Market Opportunities
  • Figure 38: PORTER's Five Force Analysis